Table 1.
Baseline clinicopathological and molecular characteristics of the study subjects (n=114)
| Variables | N(%) |
|---|---|
| Histological Grade | |
| I | 7(6) |
| II | 32(28) |
| III | 39(34) |
| Missing | 36(32) |
| Estrogen Receptor | |
| Positive | 74(65) |
| Negative | 40(35) |
| Progesterone Receptor | |
| Positive | 49(43) |
| Negative | 64(56) |
| Missing | 1(1) |
| HER2 | |
| Positive | 26(23) |
| Negative | 87(76) |
| Missing | 1(1) |
| Histological Type | |
| Infiltrating Ductal | 67(59) |
| Lobular | 6(5) |
| Others/Not classified | 25(22) |
| Missing | 16(14) |
| Stage | |
| I | 19(17) |
| II | 37(33) |
| III | 36(31) |
| IV | 4(3) |
| Missing | 18(16) |